Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Probelte Biotechnologies, also referred to as ProbelteBio, is a Spain-based developer and manufacturer of nutraceutical ingredients and botanical extracts derived primarily from Mediterranean raw materials such as olive and pomegranate. The company built a reputation around scientifically supported natural ingredients for dietary supplements, including Pomanox and Mediteanox, and operated manufacturing and laboratory facilities in Murcia. In 2017, Euromed acquired Probelte Biotechnologies as an add-on acquisition to expand its fruit- and vegetable-based nutraceutical ingredient portfolio. The acquired Murcia facility has since been described by Euromed as a state-of-the-art, environmentally friendly extraction site for Mediterranean fruit and vegetable extracts. The business is healthcare-related through nutraceuticals and natural health ingredients rather than prescription therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Probelte Biotechnologies.